Dasatinib in relapsed or plateau-phase multiple myeloma

Leuk Lymphoma. 2009 Jan;50(1):137-40. doi: 10.1080/10428190802563363.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Dasatinib
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • Neoplasm Staging
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Salvage Therapy*
  • Survival Rate
  • Thiazoles / therapeutic use*

Substances

  • Pyrimidines
  • Thiazoles
  • Dasatinib